Drafts — every reply from a prospect comes back here.

What you do: Review reply drafts and respond on your timeline.
What Ataski does: Classifies each reply, drafts a contextual follow-up that picks up the thread, blocks auto-send.
Why you can trust it: Same approval gate as first-touch — your voice, your click.

Demo data — every form submission is intercepted.

Исходящие — Очередь одобрения

4 черновик(ов) ждёт вашей проверки. Каждый оценён относительно вашего ICP, составлен Sonnet и проверен вторым ИИ от другого поставщика перед постановкой в очередь.

Needs your attention — 1 draft refused by supervisor

The cross-family supervisor flagged these drafts. Edit them, skip them, or click Replace to try a different candidate from the cache. Approve all below skips these rows — they only ship after you action each one.

Priya Mehta — Head of Revenue Operations

Mailroom Cloud · priya@mailroom.example · LinkedIn

Кампания: Series A B2B SaaS — Heads of RevOps · ИИ-супервизор: refused

Quick question on Mailroom's BI stack

Worker fabricated a '9-day build queue' claim without source. Rewrite or skip.

Ready to approve — 3 drafts

Maya Okonkwo — Head of RevOps

Cobalt Forge · maya@cobaltforge.example · LinkedIn

Кампания: Series A B2B SaaS — Heads of RevOps · ИИ-супервизор: approved

Cutting RevOps tooling sprawl at Cobalt Forge

Maya, saw your post on Cobalt Forge's RevOps tooling audit last quarter — 14 vendors down to 6 is rare to see land cleanly...

Jordan Reyes — VP RevOps

Helix Robotics · jordan@helixrobotics.example · LinkedIn

Кампания: Series A B2B SaaS — Heads of RevOps · ИИ-супервизор: approved_with_edits

Pipeline coverage question — Helix Robotics

Jordan, caught the Helix engineering blog post about pulling deal-stage data into your Linear workflows...

Sam Liu — Director RevOps

Pelican Health · sam@pelicanhealth.example · LinkedIn

Кампания: Series A B2B SaaS — Heads of RevOps · ИИ-супервизор: approved

RevOps tooling at Pelican Health

Sam, noticed Pelican Health is hiring its second Senior RevOps Analyst this quarter...